You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海吉亞醫療(06078.HK)與邯鄲仁和醫院及開遠解化醫院分別訂立藥品採購協議
格隆匯 09-14 22:52

格隆匯9月14日丨海吉亞醫療(06078.HK)公吿,於2021年9月14日,(i)公司的全資附屬公司棲海醫藥與邯鄲仁和醫院及開遠解化醫院分別訂立藥品採購協議;及(ii)公司的全資附屬公司江蘇供應鏈與邯鄲仁和醫院及開遠解化醫院分別訂立醫療耗材採購協議。

根據該等採購協議,棲海醫藥及江蘇供應鏈各自同意根據協議載列的條款及條件分別向邯鄲仁和醫院及開遠解化醫院供應醫院運營不時需要的,且在棲海醫藥及江蘇供應鏈經營許可範圍內的藥品(包括但不限於腫瘤藥品及抗生素)及醫療耗材(包括但不限於輸注耗材及血液淨化耗材)。

棲海醫藥及江蘇供應鏈均為公司的全資附屬公司,主要業務分別為銷售藥品及醫療耗材。董事認為,棲海醫藥及江蘇供應鏈(作為一方),分別與邯鄲仁和醫院及開遠解化醫院(作為另一方)訂立該等採購協議在商業維度對集團及旗下醫院有利,原因為與向其他外部第三方供應商進行採購相比,訂立該等採購協議使得集團可通過集中採購為該等醫院提供穩定的供應,可提升該等醫院的經營效率和集團對旗下醫院的服務水平。訂立該等採購協議還可以提高集團旗下醫院的服務質量,更好的滿足患者日益增長的需求。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account